BackNgm Biopharmaceuticals Overview

Ngm Biopharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NGM.

Quarterly EBIT

-$29.66M
↑ 22.54% YoY

As of Dec 31, 2023

Annual EBIT (TTM)

-$152.07M
↑ 8.53% YoY

Trailing 12 months ending Dec 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin